- Home
- NMRK vs TMDX Comparison
NMRK vs TMDX Comparison
Compare NMRK & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMRK | TMDX |
|---|---|---|
| Founded | 1929 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.8B |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NMRK | TMDX |
|---|---|---|
| Price | $16.04 | $100.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $18.75 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 1.2M | 807.3K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | 100.00 | ★ 382.18 |
| EPS | 0.68 | ★ 4.87 |
| Revenue | ★ $3,294,024,000.00 | $605,494,000.00 |
| Revenue This Year | $12.45 | $24.25 |
| Revenue Next Year | $8.02 | $18.75 |
| P/E Ratio | $23.71 | ★ $20.58 |
| Revenue Growth | 20.29 | ★ 37.13 |
| 52 Week Low | $10.20 | $89.65 |
| 52 Week High | $19.84 | $156.00 |
Technical Indicators
Market Signals| Indicator | NMRK | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 55.19 | 38.23 |
| Support Level | $13.66 | $93.08 |
| Resistance Level | $17.92 | $120.60 |
| Average True Range (ATR) | 0.61 | 5.24 |
| MACD | -0.02 | -0.83 |
| Stochastic Oscillator | 46.04 | 12.82 |
Price Performance
Historical ComparisonAbout NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.